| First Author | Garimella V | Year | 2020 |
| Journal | J Neuroimmunol | Volume | 339 |
| Pages | 577118 | PubMed ID | 31790981 |
| Mgi Jnum | J:292421 | Mgi Id | MGI:6448866 |
| Doi | 10.1016/j.jneuroim.2019.577118 | Citation | Garimella V, et al. (2020) The contribution of cyclophilin A to immune-mediated central nervous system inflammation. J Neuroimmunol 339:577118 |
| abstractText | Cyclophilin A has multiple known functions in inflammation. Intracellular cyclophilin A modulates T helper 2 response (Th2) and extracellular cyclophilin A functions as a leukocyte chemotactic factor. The contribution of cyclophilin A to central nervous system (CNS) inflammation has not been reported. To test the hypothesis that inhibition of cyclophilin A would ameliorate immune-mediated CNS inflammation, we compared the course and neuroimmunology of experimental allergic encephalomyelitis (EAE) in cyclophilin A knockout mice and wild type littermates. There was a trend towards lower incidence of EAE in cyclophilin A knockout mice, but the clinical course of EAE among animals that manifested clinical signs of EAE was similar in cyclophilin A knockout and wild type littermates. Antigen recall response to myelin oligodendrocyte glycoprotein (MOG) peptide showed that interferon-gamma release was lower in cyclophilin A knockout mice. Analysis of CNS inflammatory cells showed that CD3+ T cell infiltration into the CNS was lower in cyclophilin A knockout mice. These results showed that the loss of cyclophilin A results in altered peripheral immune activation and CNS leukocyte infiltration, but these changes did not result in a substantial change in the clinical course of EAE. |
